Abstract
Background
The association of diffuse, low-grade glioma (DLGG) with other intracranial pathologies is a rare condition, raising the question of what constitutes its most effective therapeutic management. It is not known whether this is a simple coincidence or whether there is a higher significant risk involved with the co-existence of DLGG and another disease. We report the first consecutive series of nine patients who underwent surgical resection for such a glioma.
Method
We reviewed DLGGs removed between 1998 and 2013 that were associated with another intracranial pathology. For all cases, we collected and analyzed information regarding clinico-radiological features, surgical procedures, and clinical outcomes.
Results
Nine consecutive patients (four men, five women, mean age: 38.8 years) presented with a conjunction of DLGG and another disease: two cases of vestibular schwannoma, two pituitary adenomas, two meningiomas, one lymphoma, one arteriovenous malformation, and one case of multiple sclerosis. The DLGG was diagnosed because of seizures in four patients and incidentally in the other five patients. The average delay between the diagnosis of the glioma and its resection was 40.8 months (range 1–84 months). The mean follow-up after surgery was 43 months (6–120 months). Gross-total or subtotal resection was achieved in all cases. There were no cases of mortality or permanent morbidity associated with surgery. The Karnofsky Performance Scale score was 90 or 100 in all cases. The associated pathology was treated surgically in three cases, medically in four cases, and tracked under observation in two cases. These intracranial diseases, especially meningiomas and pituitary adenomas, might have a significant higher risk to be associated with DLGGs in comparison with their incidence and prevalence in the general population.
Conclusions
Active management of this rare, dual pathology allows patients to enjoy a normal and prolonged quality of life. We therefore suggest considering early and maximal surgical resection as the first therapeutic option for DLGGs combined with another intracranial disease, as is done in the case of isolated DLGGs.
Similar content being viewed by others
References
Andrioli GC, Zuccarello M, Scanarini M, d'Avella D (1981) Concurrent primary intracranial tumours of different histogenesis. Acta Neuropathol 7:111–115
Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T (2009) Cancer risk among patients with multiple sclerosis and their parents. Neurology 72:1170–1177
Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791
Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, Young WL (2000) The epidemiology of brain arteriovenous malformations. Neurosurgery 47:389–396
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H (2013) Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases. J Neurosurg 118:1157–1168
Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM (2008) Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109:817–824
Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A, RARECARE working group (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48:1532–1542
Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology 3:152–158
De Benedictis A, Moritz-Gasser S, Duffau H (2010) Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas. Neurosurgery 66:1074–1084
De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30:2559–2565
Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005–2009. Neuro-Oncology 14(suppl 5):v1–v49
Duffau H (2012) Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir (Wien) 154:575–584
Duffau H (2012) The rationale to perform early resection in incidental diffuse low-grade glioma: towards a “preventive surgical neurooncology.” World Neurosurg [Epub ahead of print]
Duffau H (2013) Diffuse Low-Grade Gliomas in Adults Natural History, Interaction with the Brain, and New Individualized Therapeutic Strategies. Duffau H (Ed.). Springer London, pp1-491
Duffau H, Gatignol P, Mandonnet E, Capelle L, Taillandier L (2008) Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere. J Neurosurg 109:461–471
Duffau H, Lopes M, Arthuis F, Bitar A, Sichez J-P, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76:845–851
Fernandez A, Karavitaki N, Ansorge O, Fazal-Sanderson V, Wass JAH (2007) Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation? Pituitary 11:325–330
Fewings PE, Bhattacharyya D, Crooks D, Morris K (2002) B cell non-Hodgkin cerebral lymphoma associated with an anaplastic oligodendroglioma. Clin Neuropathol 21:243–247
Fontana E, Gaillard R (2009) Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse 5:2172–2174
Furtado SV, Dadlani R, Ghosal N, Mahadevan A, Shankar SK, Hegde AS (2009) Co-existing thyrotropin secreting pituitary adenoma and low grade glioma: clinical considerations and literature review. J Neurosurg Sci 53:71–75
Gazzeri R, De Bonis C, Carotenuto V, Catapano D, D'Angelo V, Galarza M (2011) Association between cavernous angioma and cerebral glioma. Report of two cases and literature review of so-called angiogliomas. Neurocirugia 22:562–526
Gil Robles S, Duffau H (2010) Surgical management of World Health Organization Grade II gliomas in eloquent areas: the necessity of preserving a margin around functional structures? Neurosurg Focus 28(2):E8
Héroum C, Schmidt C, Rigau V, Bouhya S, Duffau H (2010) Association of brain lymphoma and WHO grade II oligodendroglioma in a same immunocompetent patient. J Clin Oncol 28:729–731
Hoffman S, Propp JM, McCarthy BJ (2006) Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro-Oncology 8:27–37
Iacoangeli M, Colasanti R, Di R, Alvaro L, Nocchi N, Polonara G, Di Somma LG, Zizzi A, Scarpelli M, Scerrati M (2012) Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. Onco Targets Ther 5:357–361
Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs. a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888
Jentoft M, Giannini C, Cen L, Scheithauer BW, Hoesley B, Sarkaria JN, Abell-Aleff PC, Rodriguez EF, Li Y, Rodriguez FJ (2010) Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset. Int J Clin Exp Pathol 4:43–57
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of Chemotherapeutic Agents. Columbia University Press, New York, pp 191–205
Khalil A, Serracino H, Damek DM, Ney D, Lillehei KO, Kleinschmidt-DeMasters BK (2012) Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neurooncol 109:261–272
Kingwell E, Bajdik C, Phillips N, Zhu F, Oger J, Hashimoto S, Tremlett H (2012) Cancer risk in multiple sclerosis: findings from British Columbia, Canada. Brain 135:2973–2979
Lee EJ, Chang CH, Wang LC, Hung YC, Chen HH (2002) Two primary brain tumors, meningioma and glioblastoma multiforme, in opposite hemispheres of the same patient. J Clin Neurosci 9:589–591
Lin D, Hegarty JL, Fischbein NJ, Jackler RK (2005) The prevalence of “incidental” acoustic neuroma. Arch Otolaryngol Head Neck Surg 131:241–214
Lombardi D, Scheithauer BW, Piepgras D, Meyer FB, Forbes GS (1991) “Angioglioma” and the arteriovenous malformationglioma association. J Neurosurg 75:589–596
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
Malmgren RM, Detels R (1984) Verity MA (1984) Co-occurrence of multiple sclerosis and glioma–case report and neuropathologic and epidemiologic review. Clin Neuropathol 3:1–9
McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER (1998) Jr (1998) Factors associated with survival in patients with meningioma. J Neurosurg 88:831–839
Nazek M, Mandybur TI, Kashiwagi S (1988) Oligodendroglial proliferative abnormality associated with arteriovenous malformation: report of three cases with review of the literature. Neurosurgery 23:781–785
Neyns B (2008) Non-Hodgkin’s lymphoma in patients with glioma treated with Temozolomide. J Clin Oncol 26:4517–4518
Nielsen NM, Rostgaard K, Rasmussen S, Koch-Henriksen N, Storm HH, Melbye M, Hjalgrim H (2006) Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 118:979–984
Pallud J, Belaid H, Guillevin R, Vallee JN, Capelle L (2009) Management of associated glioma and arteriovenous malformation—the priority is the glioma. Br J Neurosurg 23:197–198
Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental world health organization grade II gliomas. Ann Neurol 68:727–733
Palma L, Mastronardi L, Celli P, D'Addetta R (1995) Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term "angioglioma". Acta Neurochir (Wien) 133:169–173
Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro-Oncology 12:520–527
Potts MB, Smith JS, Molinaro AM, Berger MS (2012) Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg 116:365–372
Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y (2012) Primary brain tumours in adults. Lancet 379:1984–1996
Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B, Bessaoud F, Bauchet F, Attaoua R, Fabbro-Peray P, Fabbro M, Kerr C, Taillandier L, Duffau H, Figarella-Branger D, Costes V, Bauchet L (2011) French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 21:633–644
Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139
Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345
Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W, European Federation of Neurological Societies (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124–1133
Spallone A, Santoro A, Palatinsky E, Giunta F (1991) Intracranial meningiomas associated with glial tumours: a review based on 54 selected literature cases from the literature and 3 additional personal cases. Acta Neurochir (Wien) 110:133–139
Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology 4:278–299
Yordanova YN, Moritz-Gasser S, Duffau H (2011) Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article J Neurosurg 115:232–239
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vassal, M., Rigau, V., de Champfleur, N.M. et al. Surgical management of diffuse low-grade gliomas associated with other intracranial diseases. Acta Neurochir 156, 339–347 (2014). https://doi.org/10.1007/s00701-013-1950-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-013-1950-3